SAba Sile
Corporate Officer/Principal bei SPRUCE BIOSCIENCES, INC.
Aktive Positionen von SAba Sile
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Corporate Officer/Principal | 10.11.2022 | - |
Karriereverlauf von SAba Sile
Ehemalige bekannte Positionen von SAba Sile
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - | - |
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | - | - |
Ausbildung von SAba Sile
| University of Pittsburgh School of Medicine | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Irland | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| SPRUCE BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
